Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Joe on +44 1494 818011 or joe@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Joe Moore
Operations Director
joe@zenopa.com
+44 1494 818011

Testimonials
I just wanted to express my thanks to the team at Zenopa for helping me gain an exciting new position with my new employer, you were a huge help.
Kate, 2011

Reckitt Benckiser launches new painkiller Nuromol

29 June 2011 00:00 in Pharmacy Supplier News


Reckitt Benckiser is launching a new over-the-counter painkiller product in the UK that combines the effects of two active ingredients.

Nuromol is now being sold through UK pharmacies and is the first clinically proven product released in this country to combine ibuprofen and paracetamol into a single tablet.

Both of these compounds are well-established in the market but work to combat pain in different ways, with Nuromol having been designed to take advantage of this and deliver stronger results than either agent on its own.

The manufacturer is recommending the new drug to those suffering from intense migraine and period pains, or for dental patients who have just undergone a tooth extraction.

Trevor Gore, training manager for healthcare at Reckitt Benckiser, said: "Nuromol is available without a prescription in pharmacies across the country."

According to the firm's most recent financial report, Reckitt Benckiser generated 2.28 billion pounds in the first quarter of 2011, up by 15 percent year on year.ADNFCR-8000103-ID-800603732-ADNFCR

Other news stories from 29/06/2011

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd